Citius Pharmaceuticals, Inc.
CTXR
$0.83
$0.011.80%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
3/10/2026
-
PR Newswire
3/6/2026
-
Insider Monkey
3/6/2026
-
Insider Monkey
3/4/2026
-
TipRanks Financial Blog
3/4/2026
-
PR Newswire
2/24/2026
-
The Fly
2/24/2026
-
PR Newswire
2/13/2026
-
Benzinga
2/13/2026
-
The Fly
2/13/2026
-
The Fly
Citius Pharmaceuticals, Inc. Announces First Reported Revenue Following Successful Launch of LYMPHIR
2/13/2026
-
PR Newswire
2/13/2026
-
PR Newswire
2/12/2026
-
Simply Wall St
2/11/2026
-
PR Newswire
12/24/2025
-
Benzinga
12/23/2025
-
Nasdaq News: Markets
12/23/2025
-
GuruFocus
Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update
12/23/2025
-
GuruFocus
12/23/2025
-
GuruFocus
12/23/2025
-
Seeking Alpha - Healthcare
12/23/2025
-
SeekingAlpha.com: All News
12/23/2025
-
SeekingAlpha.com: All News
12/23/2025
-
PR Newswire
Citius Pharmaceuticals, Inc. Reports Fiscal Year 2025 Financial Results and Provides Business Update
12/23/2025
-
PR Newswire
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Friday, February 13, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 11 and 15 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
908 967 6677
Address
11 Commerce Drive
Cranford, NJ 07016
Cranford, NJ 07016
Country
Year Founded
Business Description
Sector
Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA-approved product, is a targeted...
more